Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network

By Perumal Deepak   Samal Areejit   Sakharkar Kishore R.   Sakharkar Meena K.  

Journal of Drug Targeting, Vol. 19, Iss. 1, 2011-01 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data

By Nyberg Fredrik   Barratt Bryan J   Mushiroda Taisei   Takahashi Atsushi   Jawaid Ansar   Hada Shuji   Umemura Takaaki   Fukuoka Masahiro   Nakata Koichiro   Ohe Yuichiro   Kato Harubumi   Kudoh Shoji   March Ruth   Nakamura Yusuke   Kamatani Naoyuki  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 965-975

Future Medicine

Access to resources Recommend Favorite

Interstitial Lung Disease in Lung Cancer: Separating Disease Progression from Treatment Effects

By Sarah Danson  

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 103-113

Adis International

Access to resources Recommend Favorite

Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer

By Lo Peter C.   Dahlberg Suzanne E.   Nishino Mizuki   Johnson Bruce E.   Sequist Lecia V.   Jackman David M.   Jänne Pasi A.   Oxnard Geoffrey R.  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2570-2577

Blackwell Publishing

Access to resources Recommend Favorite